<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05058898</url>
  </required_header>
  <id_info>
    <org_study_id>2019-047</org_study_id>
    <nct_id>NCT05058898</nct_id>
  </id_info>
  <brief_title>A One Health Study of Monkeypox Human Infection</brief_title>
  <acronym>AFRIPOX</acronym>
  <official_title>A One Health Study of Monkeypox Human Infection, Animal Reservoir, Disease Ecology and Diagnostic Tools</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Pasteur</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut Pasteur de Bangui</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Pasteur</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multidisciplinary project aim to understand the epidemiology of the monkeypox in Central&#xD;
      African Republic through the identification of the animal reservoir, the clinical and&#xD;
      epidemiological description of the human outbreak, through an ethnological approach around&#xD;
      risk factors of the disease and through an ecological approach of the ecological context of&#xD;
      emergence, and the improvement of biological diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project is composed by monkyepox disease outbreak investigation in the CAR following&#xD;
      national surveillance framework.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of monkeypox cases occuring following interhuman exposures</measure>
    <time_frame>36 months</time_frame>
    <description>through a quantitative case-control study with an odds ratio of &gt;3 for an exposure factor for human-to-human transmission.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of monkeypox cases occuring following zoonotic exposures</measure>
    <time_frame>36 months</time_frame>
    <description>through a quantitative case-control study with an odds ratio of &gt;3 for an exposure factor for zoonotic transmission.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of the Effective reproduction rate R in CAR according to the level of immunity (smallpox vaccine immunity or orthopoxvirus-related post disease immunity).</measure>
    <time_frame>36 months</time_frame>
    <description>measurement of the level of population natural immunity and post vaccinal immunity to determine the Effective reproduction rate R and changes in R between 2000-2020 according to the evolution of immunity (smallpox vaccine immunity or orthopoxvirus-related post disease immunity).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>measurement of the sensitivity and the specificity of the existing diagnostic tests and those developed within the framework of the project</measure>
    <time_frame>36 months</time_frame>
    <description>sensitivity and specificity of the existing diagnostic tests and those developed within the framework of the project, as well as the reproducibility of measurements in relation to reference tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification and interpretation of genomic viral mutations from the viral sequences isolated from humans and animals in CAR for Phylogenetic and phylogeographic study of the monkeypox virus</measure>
    <time_frame>36 months</time_frame>
    <description>identification and interpretation of mutations, search for the common ancestor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of genetic proximities between different viral strains isolated in humans and animals in CAR and neighboring countries since 1980.</measure>
    <time_frame>36 months</time_frame>
    <description>Comparison of genetic proximities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of the characteristics associated with the environments in which human cases of monkeypox virus infection have occurred</measure>
    <time_frame>36 months</time_frame>
    <description>ecosystems and their recent modifications, land use, associated climatic/meteorological elements in the tropical zone (CAR, Northern DRC...).</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Monkeypox Virus Infection</condition>
  <arm_group>
    <arm_group_label>Risk factors transmission cases</arm_group_label>
    <description>Human cases of monkeypox confirmed by PCR</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Risk factors transmission contacts and co-exposures</arm_group_label>
    <description>Human contact of confirmed monkeypox cases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Serological follow up cases</arm_group_label>
    <description>Human cases of monkeypox confirmed by PCR from Lobaye region</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Serological follow up contacts and co-exposures</arm_group_label>
    <description>Human contact of confirmed monkeypox cases from Lobaye region adjusted for age, month of the year and village of origin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <description>5 mL</description>
    <arm_group_label>Risk factors transmission cases</arm_group_label>
    <arm_group_label>Risk factors transmission contacts and co-exposures</arm_group_label>
    <arm_group_label>Serological follow up cases</arm_group_label>
    <arm_group_label>Serological follow up contacts and co-exposures</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Scabs and pus samples</intervention_name>
    <description>if available</description>
    <arm_group_label>Risk factors transmission cases</arm_group_label>
    <arm_group_label>Serological follow up cases</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, scabs and pus&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The populations concerned by the study correspond to the sedentary populations known as&#xD;
        &quot;Bantus&quot; and the more mobile populations known as &quot;pygmies. These populations belong to&#xD;
        different ethno-linguistic groups with more or less specific forest uses and subsistence&#xD;
        practices: some are slash-and-burn farmers (Ngbaka, Bagando, Monzombo), others are more&#xD;
        mobile and traditionally hunter-gatherers, but now practice agriculture (Bayaka &quot;Pygmies&quot;).&#xD;
&#xD;
        Translated with www.DeepL.com/Translator (free version)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Human population in villages affected by monkeypox epidemics: patients who developed&#xD;
             monkeypox and their contacts&#xD;
&#xD;
          -  Health care personnel (paramedics, nurses, doctors) who work or have worked in&#xD;
             affected villages&#xD;
&#xD;
          -  Traditional healers, diviners&#xD;
&#xD;
          -  Members of villages affected by past monkeypox epidemics&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  area not accessible to investigation&#xD;
&#xD;
          -  refusal to participate&#xD;
&#xD;
          -  inability to obtain consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emmanuel Nakouné Yandoko, PhD</last_name>
    <phone>+23672107920</phone>
    <email>emmanuel.nakoune@pasteur-bangui.cf</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arnaud Fontanet, Pr</last_name>
    <email>arnaud.fontanet@pasteur.fr</email>
  </overall_contact_backup>
  <link>
    <url>https://research.pasteur.fr/fr/project/afripox/</url>
    <description>Institut Pasteur Afripox</description>
  </link>
  <reference>
    <citation>Besombes C, Gonofio E, Konamna X, Selekon B, Grant R, Gessain A, Berthet N, Manuguerra JC, Fontanet A, Nakouné E. Intrafamily Transmission of Monkeypox Virus, Central African Republic, 2018. Emerg Infect Dis. 2019 Aug;25(8):1602-1604. doi: 10.3201/eid2508.190112. Epub 2019 Aug 17.</citation>
    <PMID>31216261</PMID>
  </reference>
  <reference>
    <citation>Berthet N, Descorps-Declère S, Besombes C, Curaudeau M, Nkili Meyong AA, Selekon B, Labouba I, Gonofio EC, Ouilibona RS, Simo Tchetgna HD, Feher M, Fontanet A, Kazanji M, Manuguerra JC, Hassanin A, Gessain A, Nakoune E. Genomic history of human monkey pox infections in the Central African Republic between 2001 and 2018. Sci Rep. 2021 Jun 22;11(1):13085. doi: 10.1038/s41598-021-92315-8.</citation>
    <PMID>34158533</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>September 24, 2021</study_first_submitted>
  <study_first_submitted_qc>September 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidemiology</keyword>
  <keyword>outbreak investigation</keyword>
  <keyword>anthropology,</keyword>
  <keyword>animal reservoir</keyword>
  <keyword>zoonotic disease</keyword>
  <keyword>field diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Monkeypox</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

